VORONOI Receives KHIDI President’s Commendation for Global Open Innovation Achievements
VORONOI (KOSDAQ: 310210), a targeted therapy development company in South Korea, announced on September 9 that it has received a commendation from the President of the Korea Health Industry Development Institute (KHIDI) at the 2026 Bio-Health Global Open Innovation Promotion Awards.Organized by KHI…